Occam Places CEO Shakti Narayan, JD, PhD for Oncology Biotech Accent Therapeutics
In September 2019, Occam recruited Shakti Narayan, JD, PhD, as Chief Executive Officer of Accent Therapeutics. Narayan is a highly accomplished and very evolved biotech strategy and business development leader with a long suit in oncology.
Narayan most recently served as the Chief Business Officer at Tango Therapeutics, where he was responsible for finance, business development, and operational functions. While at Tango, he led a partnership with Gilead Sciences valued at $1.7 billion, which proved transformational. Prior to his work at Tango, Narayan was the VP and Head of Transactions at Johnson & Johnson Innovation, where he helped establish J&J's Innovation Centers model and led oncology business development. Narayan began his biotech career in business development at Genentech.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.